Warning: Declaration of Cmdiscwelc_Walker_PostDropdown::walk($elements, $max_depth) should be compatible with Walker::walk($elements, $max_depth, ...$args) in /home/myesopha/public_html/wp-content/plugins/cm-disclaimer-and-welcome/shared/functions.php on line 478
C2 Therapeutics Receives FDA Clearance – c2cyroballoon.com

C2 Therapeutics Receives FDA Clearance

//C2 Therapeutics Receives FDA Clearance

C2 Therapeutics’ Receives FDA Clearance for Next Generation Cryoballoon Ablation System

Redwood City, Calif. – August 22, 2013 – C2 Therapeutics, a privately held company founded to improve treatment of precursors to esophageal cancer (Barrett’s Esophagus), today announced that it received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Cryoballoon Focal Ablation System.  This is the company’s second 510(k) clearance and will be working to introduce Cryoballoon ablation in the United States.  nitial Human Experience with a Novel Through-the-scope Cryoballoon Device for Mucosal Ablation …

Click here to see full release.

2018-05-30T19:48:05+00:00